Lupin launches generic joint pain drug in US market

Lupin launches generic joint pain drug in US market

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid

PTIUpdated: Friday, December 09, 2022, 03:17 PM IST
article-image
Image credit: Wikipedia (Representative)

Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.

RECENT STORIES

'People Have Burnt Their Fingers Being Fence Sitters, They Are Now Using Every Correction To Come...
'People Have Burnt Their Fingers Being Fence Sitters, They Are Now Using Every Correction To Come...
Signature Global To Launch Branded Luxury Housing In Gurugram With ₹5,000 Crore Revenue Potential
Signature Global To Launch Branded Luxury Housing In Gurugram With ₹5,000 Crore Revenue Potential
Top 10 Firms Lose Over ₹3 Lakh Crore In Market Value; TCS, Infosys Lead Heavy Declines
Top 10 Firms Lose Over ₹3 Lakh Crore In Market Value; TCS, Infosys Lead Heavy Declines
'India Is Improving Both In Terms Of Economic Backgrounds & Business Fundamentals': Unilever CEO
'India Is Improving Both In Terms Of Economic Backgrounds & Business Fundamentals': Unilever CEO
Delhi-NCR Housing Prices Rise 6% in 2025 After 49% Surge in 2024, Bengaluru Tops With 13% Growth:...
Delhi-NCR Housing Prices Rise 6% in 2025 After 49% Surge in 2024, Bengaluru Tops With 13% Growth:...